Catherine C. Turkel - 12 Aug 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Issuer symbol
LEXX
Transactions as of
12 Aug 2024
Net transactions value
+$5,008
Form type
4
Filing time
13 Aug 2024, 10:55:35 UTC
Previous filing
30 Jul 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $5,008 +1,600 +107% $3.13 3,100 12 Aug 2024 Direct
holding LEXX common shares 1,500 12 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 3,400 12 Aug 2024 Common Shares 3,400 $3.04 Direct
holding LEXX Stock Options 5,000 12 Aug 2024 Common Shares 1,600 $1.96 Direct
holding LEXX Stock Options 10,000 12 Aug 2024 Common Shares 5,000 $0.8700 Direct
holding LEXX Stock Options 15,000 12 Aug 2024 Common Shares 5,000 $2.36 Direct
holding LEXX Stock Options 27,000 12 Aug 2024 Common Shares 12,000 $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.